Please assess the completion status of the following clinical trial:

Trial Title: Study Assessing the Effect of 3-week Treatment With One of Three Oral Doses of Quinagolide

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE2
- Number of Arms: 4.0

Eligibility Criteria:
Inclusion Criteria~1. Signed Informed Consent Form, prior to screening evaluations~2. In good physical and mental health~3. Pre-menopausal females between the ages of 21-37 years (both inclusive) at the time of randomisation~4. Infertility for at least 1 year before randomisation, except for proven bilateral tubal infertility~Exclusion Criteria~1. Any clinically significant systemic disease~2. Endocrine or metabolic abnormalities (pituitary, adrenal, pancreas, liver or kidney)~3. History of recurrent miscarriage~4. Undiagnosed vaginal bleeding

- Gender: FEMALE
- Minimum Age: 21 Years
- Maximum Age: 37 Years
- Healthy Volunteers: f

Study Arms:
- 1 (Type: PLACEBO_COMPARATOR): Daily Tablets Dosing
- 2 (Type: EXPERIMENTAL): Daily Tablets Dose
- 3 (Type: EXPERIMENTAL): Daily Tablets Dosing
- 4 (Type: EXPERIMENTAL): Daily Tablets Dosing

Based on this trial design, predict the completion outcome and termination type (if applicable).